Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.33 USD
Change Today +0.06 / 0.73%
Volume 744.7K
RGLS On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitleKey Developments
Stelios Papadopoulos Ph.D. 89 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Bruce Carter Ph.D. 194 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Mark Foletta CPA 36 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitle
David Baltimore Ph.D. 118 RelationshipsChairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Bruce Carter Ph.D. 194 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
William Rastetter Ph.D. 81 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
RGLS Compensation vs. Industry
244.7K
354.7K
Chief Financial Officer
Share price activity for REGULUS THERAPEUTICS INC (RGLS)
52 Week Price Performance
RGLS
Industry Average

Nominating Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitleKey Developments
Stelios Papadopoulos Ph.D. 89 RelationshipsChairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeRegulus Therapeutics Inc. Appoints Michael Huang, M.D. as Vice President, Clinical Development
08/25/15
David Baltimore Ph.D. 118 RelationshipsChairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeRegulus Therapeutics Inc. Announces Management Changes
06/1/15
Mark Foletta CPA 36 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeRegulus Appoints Paul C. Grint, M.D. as Chief Medical Officer
06/16/14
William Rastetter Ph.D. 81 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Compensation CommitteeRegulus Appoints Martin Beaulieu as Head of Regulus Micromarkers R&D Division
02/13/14

Corporate Governance Committee* - regulus therapeutics inc (RGLS)

Name (Connections)Board RelationshipsTitle
David Baltimore Ph.D. 118 RelationshipsChairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Mark Foletta CPA 36 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Stelios Papadopoulos Ph.D. 89 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
William Rastetter Ph.D. 81 Relationships--
RGLS and Competitor
Insiders vs. External
Board
9%
91%
Regulus Therapeutics Inc.
38%
62%
Silence Therapeutics plc
20%
80%
Benitec Biopharma Limited
8%
92%
Galena Biopharma, Inc.
29%
71%
Arbutus Biopharma Corporation
30%
70%
Dicerna Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - regulus therapeutics inc (RGLS)

Name (Board Relationships)/Title Board Affiliations
David Baltimore 118 Relationships
Chairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
No other board affiliations
David Bartel 36 Relationships
Member of Scientific Advisory Board
No other board affiliations
Gregory Hannon 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Markus Stoffel 25 Relationships
Member of The Scientific Advisory Board
No other board affiliations
Thomas Tuschl 24 Relationships
Member of The Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $8.33 USD +0.06

RGLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arbutus Biopharma Corp $7.11 USD -0.25
Benitec Biopharma Ltd A$0.55 AUD -0.01
Dicerna Pharmaceuticals Inc $10.97 USD -0.16
Galena Biopharma Inc $1.58 USD +0.08
Silence Therapeutics PLC 258.50 GBp -1.50
View Industry Companies
 

Industry Analysis

RGLS

Industry Average

Valuation RGLS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 31.7x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 21.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.